Khalid Islam, Director at Immunomedics, holds 930.78K shares in Gain Therapeutics (Ticker: GANX), holds 213.82K shares in Fennec Pharmaceuticals (Ticker: FENC), holds 193.40K shares in Processa Pharmaceuticals (Ticker: PCSA). Most recently, Khalid Islam Bought ― shares of Gain Therapeutics on Aug 12, 2024 for an estimated value of 49.50K.
What is the percentage of profitable transactions made by Khalid Islam?
The percentage of profitable transactions made by Khalid Islam is ―.
What is the average return per transaction made by Khalid Islam?
The average return per transaction made by Khalid Islam is ―.
What stocks does Khalid Islam hold?
Khalid Islam holds: IMMU, FENC, PCSA, GANX stocks.
What was Khalid Islam’s latest transaction?
Khalid Islam latest transaction was an Informative Buy of $49.50K.
What was Khalid Islam's most profitable transaction?
Khalid Islam’s most profitable transaction was an Informative Buy of GANX stock on August 12, 2024. The return on the trade was 136.10%.
What is Khalid Islam's role in Immunomedics?
Khalid Islam's role in Immunomedics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.